2m 2m 2m 2m 2m 2m 2m
EVOTEC SP ADS (EVO)
NASDAQ
$1.98+$0.07 (+3.66%)
Price as of Aug 03, 2026 6:32 AM EDT- $678.8MMarket Cap
- -52.49%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
EVOTEC SP ADS (EVO)
$1.98+$0.07 (+3.66%)
EVO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.91 | ||
Change | -$0.02 (-1.04%) | ||
Open | $1.93 | ||
High | $1.94 | ||
Low | $1.90 | ||
Previous Close | $1.93 | ||
Volume | 34,168 | ||
30-Day Average Volume | 62,352 | ||
1-Week Change | -1.55% | ||
1-Month Change | -31.79% | ||
1-Year Change | -52.49% | ||
3-Year Change | -85.44% | ||
5-Year Change | -84.87% | ||
Fundamentals | |||
Shares Outstanding | 355.4M | ||
Total Assets | $1.7B | ||
Market Cap | $678.8M | ||
Enterprise Value | $341.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 01/11/2019 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue